Paper_Route_Frank
Posted - 2 days ago
$XGN would like to get in at $3 or below since I missed my entry
JDubbs530
Posted - 3 days ago
$XGN 4.20
If need a better buy signal you’re not gonna get it
_www_larval_com_
Posted - 3 days ago
$ZBIO -6%[-17%] $XGN 6%[19%] $LGMK -4%[-15%] $BTOC -4%[-5%] $MSTR -3%[10%] most notable movement into the final minutes of trading.
luxm3
Posted - 3 days ago
$XGN sold half position a 3.95... great gain..
luxm3
Posted - 4 days ago
$XGN ready to go above 4$?
luxm3
Posted - 4 days ago
$XGN very high volumes. Something is cooking.
luxm3
Posted - 4 days ago
$XGN added more on the dip... now 2.9 medium price
arribaStocktrading
Posted - 4 days ago
$XGN It's about time someone stepped up and bought this company and paid around $8/share for it. They would be getting a good deal and we would too.
StockHawkZero
Posted - 4 days ago
$XGN CFO also bought 20k + shares
PenkeTrading
Posted - 4 days ago
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Exagen Inc. Is that bullish or bearish? $XGN #Exagen #RsiOverbought #NASDAQ
StockHawkZero
Posted - 5 days ago
@Jeko44 @buythehornz127 To be honest, CEO buying shares is not always the signal you think it is. Just look at $XGN
luxm3
Posted - 5 days ago
$XGN here we are... se you at 4.6...
CEOBuysDisclosures
Posted - 5 days ago
$XGN CEO purchased 24,305 shares at $2.81 for a total of $68,297. ABALLI JOHN now owns 689,799 shares. https://ceo-buys.com
luxm3
Posted - 1 week ago
$XGN Exagen Inc. (XGN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 6.67%. A quarter ago, it was expected that this company would post a loss of $0.36 per share when it actually produced a loss of $0.16, delivering a surprise of 55.56%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Exagen , which belongs to the Zacks Medical - Products industry, posted revenues of $12.51 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 7.70%. This compares to year-ago revenues of $13.42 million. The company has topped consensus revenue estimates three times over the last four quarters.
luxm3
Posted - 1 week ago
$XGN added more... see you tomorrow....
GeeMar68
Posted - 2 weeks ago
$XGN hi all !!!! I’m follower #499. Glad to be hear !!!
ChessGM
Posted - 2 weeks ago
$XGN Heads up alert! Upcoming earnings on Tuesday, 11/12/2024 for $XGN Neutral (5.0) In recent assessments of Exagen Inc. (XGN), the company appears to be navigating a complex landscape characterized by both promising developments and underlying challenges. The upcoming release of the third-quarter results on November 12, 2024, is anticipated to be a pivotal moment for the company. Analysts are keenly observing Exagen's performance, particularly given its role as a prominent player in the autoimmune testing sector. Key financial metrics such as the price-to-earnings (P/E) ratio currently stand at approximately 15, which is relatively in line with industry averages, indicating that the stock is fairly valued when considering its growth prospects. Moreover, the company's earnings per share (EPS) growth rate has shown resilience, with projections suggesting a 12% increase year-over-year, aligning with broader market trends in healthcare. Revenue forecasts are stable, with estimates suggesting a modest growth trajectory, driven primarily by the increasing demand for autoimmune testing. The acceptance of five abstracts at the 2024 American College of Rheumatology Convergence is a significant validation of Exagen's research and development efforts. This involvement not only enhances the company’s visibility within the medical community but also underscores its commitment to advancing diagnostic capabilities. However, the stock's performance must be viewed in the context of broader market conditions and competition within the sector, where peers may exhibit more aggressive growth strategies. As such, while Exagen presents a stable investment opportunity, its current standing suggests cautious optimism among investors. Looking ahead to the upcoming earnings report, expectations are tempered yet hopeful. Historical performance has demonstrated a tendency for Exagen to either meet or slightly exceed analyst consensus estimates, which currently predict revenues of around $15 million for the quarter, reflecting a growth rate of approximately 10% compared to the previous year. This consistency in performance could bolster investor confidence, especially if management provides a positive outlook during the earnings call. The potential impact of these results on the stock price could be significant, particularly if the company can effectively communicate its strategic positioning and growth plans moving forward. - Funds were net buyers of $XGN during the previous reporting quarter. - Top 1 funds with large holdings in $XGN: * RTW Investments LP $3MM. New position. CGMFundRank: 61%, Fund Website: www.rtwfunds.com - Last 10 days performance: -3% - Last 30 days performance: -8% - Last 90 days performance: -25% Follow ChessGM on stocktwits.com to get timely earnings alerts. Not a financial advice. Not a trading signal."
StockHawkZero
Posted - 10/31/24
$XGN Looks like a typical bringing of the price down with slow volumes 2 weeks before earnings release, someone's quietly accumulating.
ucantcatchmegaythots
Posted - 1 month ago
$SGN $XGN I'm going to watch these 2 today since I won't have time for new searches... and they have given hints of pump... one for continuation of reversal and one for start of reversal out of bottom
luxm3
Posted - 1 month ago
$XGN added more...very interesting
LetsWinSD
Posted - 2 months ago
$XGN something is brewing.
LetsWinSD
Posted - 2 months ago
$XGN let's see some action!
jacksparo
Posted - 2 months ago
$XGN Anyone who followed the trade plan here should be in good gain team ✅!
Ryaan888
Posted - 2 months ago
$XGN Dang y’all didn’t let me know 😓 WHERE MY DAY 1s
